NFXF Webinar Series: NIH Fragile X Centers of Excellence

The Centers for Collaborative Research in Fragile X and FMR1-related Conditions Program supports research to improve the diagnosis and treatment of Fragile X syndrome (FXS) and its related conditions. These Centers are geared toward stimulating multidisciplinary, multi-institutional research, with the common goal of facilitating the translation of basic research findings from bench to bedside and bedside to community.

The program is administered through NICHD’s Intellectual and Developmental Disabilities Branch (IDDB). The branch initially funded three Centers in fiscal year 2003 in response to the Children’s Health Act of 2000. 

“The FMR1 gene is revealing its far-reaching effects,” said Tracy King, M.D., M.P.H., medical officer in the IDD Branch at NICHD. Dr. King leads the extramural portfolio of FMR1 research for NICHD, including activities of the research centers. “These Centers will help us learn more about the gene, its related conditions and health effects, as well as ways to help individuals and families deal with these conditions.”

Join us as we hear from Tracy King, M.D., M.P.H., medical officer in the IDD Branch at NICHD, and each of the current Centers:

  • Baylor College of Medicine and University of Michigan Medical School
  • Fragile X Center at Emory University
  • Cincinnati Children’s Hospital Medical Center
 
Presenters:
  • Peter Todd and Emily Allen on behalf of Baylor College of Medicine and University of Michigan Medical School
  • Peng Jin on behalf of Fragile X Center at Emory University
  • Craig Erickson on behalf of Cincinnati Children’s Hospital Medical Center